New Version-ATTACHMENT 1-TECHNICAL-Product and Organization Details 9-2-2022 POST.xlsx
XLSX spreadsheet 18 KB Posted
- Attached to
- 75A50322Q00019 SNS Pharmaceutical Buy
- Solicitation number
- 75A50322Q00019
- Issued by
- Not on record
About this file
This document includes a solicitation for a Strategic National Stockpile pharmaceutical buy. The solicitation seeks proposals to purchase bulk pharmaceuticals for the Strategic National Stockpile, which is managed by the Division of Strategic National Stockpile within the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services. Proposals are due by August 23, 2022 and performance is anticipated to begin on September 30, 2022 for a one-year period. The solicitation will result in multiple contract awards for pharmaceutical products. Offerors may submit proposals for more than one pharmaceutical product. Evaluation will be based on representations and certifications as well as technical and price proposals, without discussions unless determined to be in the government's best interest. Questions are due by August 12, 2022.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ATTACHMENT 1- TECHNICAL INFO
| Company Name | Business Size | Item No. | Product Description | CHANGE | NDC # | Quantity in Eaches | Unit of Measure (UoM) | Eaches Per UOM | Organization Type: Manufacturer or Authorized Reseller | FDA Approved Shelf-Life | Shelf-Life at Time of Delivery | DEA License # (Controlled Substances Only) | Delivery Schedule | Oct-22 | Nov-22 | Dec-22 | Jan-23 | Feb-23 | Mar-23 | Apr-23 | May-23 | Jun-23 | Jul-23 | Aug-23 | Sep-23 |
| 1 | Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial | 2,460 | EA | ||||||||||||||||||||||
| 2 | Bacitracin zinc, (500u/gm) ointment 30gm tube | 33,048 | EA | ||||||||||||||||||||||
| 3 | Bacitracin, 500u/Polymixin 10000u, 3.5gm, opthalmic | 160,144 | EA | ||||||||||||||||||||||
| 4 | Bactrim sulfamethoxazole, 800mg/trimethoprim 160mg tablets in 100 bottle | 316,800 | EA | ||||||||||||||||||||||
| 5 | Ciprofloxacin, 250mg/5ml oral suspension, powder, 100ml bottle | 44,810 | EA | ||||||||||||||||||||||
| 6 | Clindamycin phosphate, 150mg/cc in 6cc vial | 1,441,125 | EA | ||||||||||||||||||||||
| 7 | Dextrose, 5% and .45% Sodium Chloride for injection, 1000ml solution bag | 14,210 | EA | ||||||||||||||||||||||
| 8 | Diazepam soln. for inj., 5mg/ml, x 10ml multi-dose vial | 20,000 | EA | ||||||||||||||||||||||
| 9 | Dopamine HCL solution, for injection, 400mg (40mg/ml) in a 10ml vial- | 49,050 | EA | ||||||||||||||||||||||
| 10 | Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle | QTY INCREASED | 616,550 | BT | |||||||||||||||||||||
| 11 | Lactated Ringers Injection, 1000ML | NEWLY ADDED | 10,000 | CS | |||||||||||||||||||||
| 12 | Levophed (Norepinephrine), 1mg/ml in 4ml amp | 5,400 | EA | ||||||||||||||||||||||
| 13 | Lidocaine 1% with Epinephrine 30ml vial | 8,300 | EA | ||||||||||||||||||||||
| 14 | Methylprednisolone sodium succinate for injection,125mg, 2ml powder/diluent 2 chamber vial | 9,900 | EA | ||||||||||||||||||||||
| 15 | Morphine Sulfate, 10mg/ml, 1ml, LL(luer-loc) pre-filled syringe | 1,408,700 | EA | ||||||||||||||||||||||
| 16 | Oxycodone HCL 5mg/Acetaminophen 325mg Tab | 2,315,500 | EA | ||||||||||||||||||||||
| 17 | Penicillin G Potassium 20MU | 266,000 | EA | ||||||||||||||||||||||
| 18 | Polymyxin B sulfate/bacitracin zinc double antibiotic ointment, 0.9gm foil packet | 70,992 | EA | ||||||||||||||||||||||
| 19 | Potassium Chloride solution for injection, 2mEq/ml, 20ml vial | 69,300 | EA | ||||||||||||||||||||||
| 20 | Proparacaine (Hydrochloride Ophthalmic Solution) USP 0.5% 15ML Sterile | 43,264 | EA | ||||||||||||||||||||||
| 21 | Rifampin 600mg/vial for injection | QTY DECREASED | 58,900 | EA | |||||||||||||||||||||
| 22 | Sodium Chloride (NaCL) 0.9% for injection, 100ml solution flexi-bag | 6,595,680 | EA | ||||||||||||||||||||||
| 23 | Sodium Chloride for inj., 0.9 1000ml flexi-bag | QTY DECREASED | 11,071 | CS | |||||||||||||||||||||
| 24 | Sterile water for injection, preservative free, 10ml solution vial | 480,800 | EA | ||||||||||||||||||||||
| 25 | Voriconazole 200mg 30 Tablet Bottle | 197,640 | EA | ||||||||||||||||||||||
| 26 | Xylocaine (Lidocaine) HCL MPF 1% without Epinephrine injection, 50ml (10mg/ml) in a 5 ml solution vial | 28,400 | EA |
Past Performance
| Project 1 |
| Contract # |
| Customer/Agency Name |
| Contract Title |
| Contract Type |
| Period of Performance |
| Value |
| Product Name |
| Quantity |
| Brief narrative description of the work performed, including a description of how the previous work demonstrates the Offeror’s capacity to successfully meet the requirements described in the request for proposal (RFQ) and a discussion of any problems encountered/corrective actions and significant accomplishments |
| Project 2 |
| Contract # |
| Customer/Agency Name |
| Contract Title |
| Contract Type |
| Period of Performance |
| Value |
| Product Name |
| Quantity |
| Brief narrative description of the work performed, including a description of how the previous work demonstrates the Offeror’s capacity to successfully meet the requirements described in the request for proposal (RFQ) and a discussion of any problems encountered/corrective actions and significant accomplishments |
File details come from the government source that posted it. Updated .